SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals
REGN 725.28+3.0%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (2357)4/6/2018 3:21:24 PM
From: Miljenko Zuanic1 Recommendation

Recommended By
scaram(o)uche

  Read Replies (1) of 3559
 
RE: Dupi 1Q US sale

Based on TRx/BNRx numbers, I am projecting 1Q sale at ~$175m. That is bit down than early $180-185, but it is still higher than majority analysts are projecting. In all, I see good 1Q for REGN, SGA-expense increase will be on "hold" (until PBM agree on praluent discount), so expecting better EPS for 1Q! For those who maybe care!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News